Cagrilintide 5mg × 10
Research-use disclaimer
All products are strictly for laboratory research and in-vitro studies, not for human consumption.
Description
Cagrilintide is a long-acting synthetic amylin analog that acts as a dual amylin and calcitonin receptor agonist. It suppresses appetite, enhances satiety, and slows gastric emptying, leading to significant reductions in food intake. Primarily developed for obesity and type 2 diabetes treatment, it is notably used in combination with semaglutide (CagriSema), demonstrating strong weight loss effects in clinical trials. It is generally well-tolerated, with main side effects being mild to moderate gastrointestinal discomfort. This content is for research purposes only and is provided solely for reference. It must not be interpreted as health, clinical, or legal advice or guidance.
Product research FAQ
What is this product intended for?
It is supplied strictly for laboratory research and in-vitro studies, not for human consumption.
Is batch documentation available?
Available batch-specific Certificates of Analysis are listed in the COA section on this page.
How should the product be stored?
Follow the storage information shown on this page and the instructions supplied with the specific batch.
